ABSTRACT
Purpose: To examine the hidden blood loss (HBL) in treatment of AO type A1-A3 thoracolumbar fractures with three different approaches and to explore the influential factors of HBL among patients after the surgery of internal fixation for thoracolumbar fractures. Methods: We retrospectively studied 85 patients in treatment of thoracolumbar fractures: 25 patients via percutaneous approach (Group A), 33 patients via paraspinal approach (Group B), and 27 patients via conventional open approach (Group C). The demographic information of the patients was collected. Each patient's preoperative and postoperative hematocrit were recorded and used for calculating the blood loss according to the Gross's formula. The difference of blood loss between the three groups was measured by ANOVA. And influential factors were further analyzed by multivariate linear regression analysis in each group. Results: The average HBL was 240.0 ± 65.1 mL in Group A, 313.7 ± 138.1 mL in Group B, and 382 ± 153.8 mL in Group C. There was statistical difference in the HBL between three groups (P = 0.000). However, multivariate linear regression analysis revealed that HBL of three approaches was not associated with age, gender, body mass index (BMI), percentage of height loss, percentage of height restoration, fracture type, or operation time. Conclusion: There was a substantial HBL in the treatment of thoracolumbar fractures, which was neglected by surgeons. Further investigation is necessary to study the risk factors for surgery on HBL in treatment of thoracolumbar fractures.
ABBREVIATIONS | ||
ANOVA | = | analysis of variance |
BMI | = | body mass index |
HCT | = | haematocrit |
Hb | = | haemoglobin |
HBL | = | hidden blood loss |
IBL | = | intraoperative blood loss |
LOS | = | length of hospital stay |
MI-TLIF | = | minimally invasive-transforaminal lumbar interbody fusion |
PBV | = | patient's blood volume |
PKP | = | percutaneous kyphoplasty |
PLC | = | posterior ligamentous complex |
SD | = | standard deviation |
TBL | = | total blood loss |
TXA | = | tranexamic acid |
DECLARATION OF INTEREST
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
ACKNOWLEDGMENTS
This work was supported by the National Natural Science Foundation of China (81501907); the Natural Science Foundation of Zhejiang Province (LY15H060008); and the Wenzhou Municipal Science and Technology Bureau (Y20150063, Y20140152). We thank all the colleagues for their invaluable assistance during the execution of this study.
ETHICAL APPROVAL
The study protocol of this retrospective analysis was approved by the ethics committee of our hospital (Wenzhou, Zhejiang Province, China).
INFORMED CONSENT
Due to the retrospective nature of the study, the need for informed consent was waived by the ethics committee.